[290 Pages Report] The global implantable infusion pump market is expected to reach a valuation of US$ 485.1 Million in 2022. The increasing incidence of numerous disorders such as diabetes, cancer, and various other disorders among the population, combined with the growing liability of the elderly population, advanced technology are projected to be the market's primary growth drivers. Overall sales of implantable infusion pumps are projected to grow at a robust CAGR of 5.7% between 2022 and 2032, totaling around US$ 892.6 Million by the end of 2032.
An implantable infusion pump is a medical device that administers drugs to patients via intra-arterial, intravenous, subcutaneous, intraperitoneal, intrathecal, and epidural routes. A catheter is strung into the chosen place after the pump is surgically implanted in a subcutaneous pocket in the abdominal wall.
An implantable infusion pump's primary function is to deliver fluids, such as supplements and drugs, into a patient's body in a controllable environment. Implantable infusion pump are frequently used in clinical settings such as hospitals, specialty clinics, ambulatory surgical centers, and so on.
| Data Points | Key Statistics |
|---|---|
| Implantable Infusion Pump Market Size (2022) | US$ 485.1 Million |
| Implantable Infusion Pump Market Revenue Forecast (2032) | US$ 892.6 Million |
| Implantable Infusion Pump Market Growth Rate (2022-2032) | 5.7% CAGR |
| North America Market Share | 36.7% |
The dosage is customized for each patient. The implantable infusion pump only require recharging every 1 to 3 months. When employed to deliver drugs with FDA approval for this course of obtaining to and for the associated sign for the treatment of cancer, primary liver cancer, primary epithelial ovarian cancer, metastatic colorectal cancer, severe/chronic/intractable pain, and serious spasticity of cerebral origin in patients who are unresponsive to stand for oral baclofen therapeutic interventions, these medical devices are evaluated therapeutically crucial.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The principal factors propelling the expansion of the implantable infusion pump market are rising rates of cancer, diabetes, and obesity worldwide. A significant increase in implantable drug delivery techniques via surgeries is also driving up the consumption of infusion pump.
The delivery of chemotherapy agents and analgesics are the foremost activities; numerous implantable infusion pump are industrially obtainable to end users, which will drive sales at a significant rate over the forecasting period. The innovative implantable infusion pump provide long-term drug infusion at a differential or constant rate.
Contribution to progress from top manufacturers as a result of various factors, for example, growing prevalence of chronic diseases alongside an aging population, broadening adoption of convenient & advanced implantable infusion pump to reduce hospital facility use, and enduring increase in surgical procedural volumes.
Aside from that, advancements in technology and increased spending by manufacturers for the production of better implantable infusion pump will drive the development of this market, notably in the United States and Western Europe.
However, the FDA's stringent approval regulations for implantable infusion pump will constrain the industry's growth.
Furthermore, patient care risks and medical errors while drug delivery affiliated with implantable infusion pump in desirable areas may act as a limitation to the market's expansion. Product recalls and stringent regulations for innovative products may also restrict the overall implantable infusion pump market's growth throughout the forecast period.
Principal Consultant
North America is predicted to dominate the global Implantable Infusion Pump market in the coming years and account for a share of 36.7% of the global market in 2022. This dominance is due to the increasing number of chronic diseases, the purpose of healthcare infrastructure, and the presence of significant market players in the region.
Furthermore, supportive reimbursement programs covering the costs of implantable medical devices as well as the protocol inspired individuals in the region to choose such devices. Furthermore, the surging prevalence of chronic pain in the United States is anticipated to boost the market for implantable infusion pump.
According to CDC 2020 data, 20.4% of adults had chronic pain in 2019 and 7.4% of adults had severe pain that frequently restricted life or work activities. Both increased with age and were greatest among adults 65 and older. As a result, soaring chronic pain cases are expected to increase demand for implantable infusion pump, which are surgically implanted to provide consistent drug delivery for pain management in non-cancer patients. Furthermore, recent product authorization by the US Food and Drug Administration is anticipated to expand the regional market for implantable infusion pump.
The Asia Pacific, excluding Japan, is also predicted to experience substantial growth in the Implantable Infusion Pump Market owing to increased R&D activities, saturation in the advanced economies, and the advancement of healthcare infrastructure in this region.
The Asia-Pacific region, excluding Japan, has several small players that conduct business on a regional level and contribute to a significant portion of the Implantable Infusion Pump Market industry. Improved medical infrastructure and steadily increasing disposable income in emerging economies such as China and India, among many others, are also cruising the implantable infusion pump market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for implantable infusion pump in Europe is predicted to expand at a 6.2% annual rate from 2022 to 2032. The global increase in the healthcare sector is accelerating the development of the Europe infusion pump market. Europe is accounting for a share of 29.5% of the global market in 2022.
One of the key factors driving the expansion of the implantable infusion pump market is the emergence of the prevalence of chronic illnesses throughout the region. Clamor for ambulatory implantable infusion pump in home health care settings, as well as a boost in the number of ICU beds in countries with a high prevalence of COVID-19, compel market growth.
Cancer (Oncology) is anticipated to represent the largest portion of the implantable infusion pump application segment. This is due to the rise in cases of cancer among the global population. Cancer was the second-leading cause of death globally in 2018, causing an estimated 9.6 million deaths, or one in every six deaths, according to the WHO 2021 data, and approximately 300,000 new cases of cancer are detected each year among children aged 0-19 years.
Furthermore, 9,503,710 new cancer cases were reported in Asia, according to data from the Global Cancer Observatory 2020. As a result, rising cancer cases around the world may augment growth in the oncology segment.
Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
Some leading implantable infusion pump manufacturers include B. Braun Melsungen AG., CareFusion Corporation, Fresenius Kabi AG, Terumo Corporation, Medtronic Plc., Baxter International Inc., Smiths Medical, MOOG Inc., Johnson & Johnson Private Ltd., and Hospira, Inc., Flowonix, The Tandem Diabetes Care.
These key implantable infusion pump providers are adopting various strategies such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. to increase their sales and gain a competitive edge in the global implantable infusion pump market. For instance,
The global implantable infusion pump market reached US$ 485.1 Million in 2022
As per FMI, the implantable infusion pump market is expected to grow at a CAGR of 5.7% from 2022-2032
The global sales of implantable infusion pumps are anticipated to total a valuation of US$ 892.6 Million by 2032
North America will continue to remain the most lucrative, accounting for a share of 36.7% in 2022
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2016-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 5.3.1. Patient-Controlled Analgesia Pumps 5.3.2. Enteral Pumps 5.3.3. Insulin Pumps 5.3.4. Elastomeric Pumps 5.3.5. Syringe Pumps 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2016-2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032 6. Global Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2016-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032 6.3.1. Oncology 6.3.2. Pediatrics/Neonatology 6.3.3. Gastroenterology 6.3.4. Hematology 6.3.5. Diabetes 6.4. Y-o-Y Growth Trend Analysis By Application, 2016-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 7. Global Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By End Users 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2016-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centres 7.3.3. Clinics 7.3.4. Home Healthcare 7.4. Y-o-Y Growth Trend Analysis By End Users, 2016-2021 7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032 8. Global Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. U.S. 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End Users 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End Users 9.4. Key Takeaways 10. Latin America Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End Users 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End Users 10.4. Key Takeaways 11. Europe Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. U.K. 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End Users 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End Users 11.4. Key Takeaways 12. Asia Pacific Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Malaysia 12.2.1.5. Singapore 12.2.1.6. Australia 12.2.1.7. Rest of Asia Pacific 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End Users 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End Users 12.4. Key Takeaways 13. MEA Implantable Infusion Pumps Market Analysis 2016-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End Users 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End Users 13.4. Key Takeaways 14. Key Countries Implantable Infusion Pumps Market Analysis 14.1. U.K. 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2021 14.1.2.1. By Product Type 14.1.2.2. By Application 14.1.2.3. By End Users 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2021 14.2.2.1. By Product Type 14.2.2.2. By Application 14.2.2.3. By End Users 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2021 14.3.2.1. By Product Type 14.3.2.2. By Application 14.3.2.3. By End Users 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2021 14.4.2.1. By Product Type 14.4.2.2. By Application 14.4.2.3. By End Users 14.5. Rest of Latin America 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2021 14.5.2.1. By Product Type 14.5.2.2. By Application 14.5.2.3. By End Users 14.6. Germany 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2021 14.6.2.1. By Product Type 14.6.2.2. By Application 14.6.2.3. By End Users 14.7. U.K. 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2021 14.7.2.1. By Product Type 14.7.2.2. By Application 14.7.2.3. By End Users 14.8. France 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2021 14.8.2.1. By Product Type 14.8.2.2. By Application 14.8.2.3. By End Users 14.9. Spain 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2021 14.9.2.1. By Product Type 14.9.2.2. By Application 14.9.2.3. By End Users 14.10. Italy 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2021 14.10.2.1. By Product Type 14.10.2.2. By Application 14.10.2.3. By End Users 14.11. Rest of Europe 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2021 14.11.2.1. By Product Type 14.11.2.2. By Application 14.11.2.3. By End Users 14.12. China 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2021 14.12.2.1. By Product Type 14.12.2.2. By Application 14.12.2.3. By End Users 14.13. Japan 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2021 14.13.2.1. By Product Type 14.13.2.2. By Application 14.13.2.3. By End Users 14.14. South Korea 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2021 14.14.2.1. By Product Type 14.14.2.2. By Application 14.14.2.3. By End Users 14.15. Malaysia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2021 14.15.2.1. By Product Type 14.15.2.2. By Application 14.15.2.3. By End Users 14.16. Singapore 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2021 14.16.2.1. By Product Type 14.16.2.2. By Application 14.16.2.3. By End Users 14.17. Australia 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2021 14.17.2.1. By Product Type 14.17.2.2. By Application 14.17.2.3. By End Users 14.18. Rest of Asia Pacific 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2021 14.18.2.1. By Product Type 14.18.2.2. By Application 14.18.2.3. By End Users 14.19. GCC Countries 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2021 14.19.2.1. By Product Type 14.19.2.2. By Application 14.19.2.3. By End Users 14.20. South Africa 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2021 14.20.2.1. By Product Type 14.20.2.2. By Application 14.20.2.3. By End Users 14.21. Israel 14.21.1. Pricing Analysis 14.21.2. Market Share Analysis, 2021 14.21.2.1. By Product Type 14.21.2.2. By Application 14.21.2.3. By End Users 14.22. Rest of MEA 14.22.1. Pricing Analysis 14.22.2. Market Share Analysis, 2021 14.22.2.1. By Product Type 14.22.2.2. By Application 14.22.2.3. By End Users 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End Users 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. B. Braun Melsungen AG. 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.2. CareFusion Corporation 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.3. Fresenius Kabi AG 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.4. Terumo Corporation 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.5. Medtronic Plc. 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.6. Baxter International Inc. 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.7. Smiths Medical 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.8. MOOG Inc., 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.9. Johnson & Johnson Private Ltd. 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.10. Pfizer 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Healthcare
July 2017
REP-GB-3525
September 2022
250 pages
Explore Healthcare Insights
View Reports
Implantable Infusion Pump Market
